In the proposed mechanism of action, the membrane-permeable T-DXd payload can destroy targeted tumor cells expressing HER2 and diffuse into neighboring cells, regardless of HER2 status; this is known as the bystander antitumor effect [51,52,53,54]. Here, ERBB2 is linked to neoplasm.